Drug Database
Back to search

Japan· JP-2399008F1110

イトプリド塩酸塩

A itroprid product containing イトプリド塩酸塩, registered in Japan by 沢井製薬, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

On Japan’s NHI price listATC A03FA07

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedイトプリド塩酸塩ATCA03FA07REGISTER NO.JP-2399008F1110PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about イトプリド塩酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Itroprid is registered in 8 of 19 countries.

Countries holding a registration under ATC A03FA07 (itroprid), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 5 of them publish a price we can compare per daily dose
Search itroprid products by name

Itroprid · ATC A03FA07

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
イトプリド塩酸塩
Manufacturer
沢井製薬
Country
Japan (JP)
ATC code
A03FA07
ATC class
Itroprid
Defined daily dose
0.15 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A03FA07

Itroprid, as other registers publish it.

All itroprid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b65b880b-3fb7-436b-9dc0-b113f1009ab5
GET /v1/drugs/b65b880b-3fb7-436b-9dc0-b113f1009ab5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５０ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2399008F1110",
  "category": "内用薬",
  "price_yen": 6.3,
  "generic_name": "イトプリド塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2399",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about itroprid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console